Understanding How MS Patients Use and Stay on a New Treatment

This study is looking at how patients with multiple sclerosis use and stay on a medication called Ocrevus Zunovo. Researchers want to understand what makes it easier or harder for people to start and continue this treatment, by listening to patients, doctors, administrators, and insurance experts about their real-world experiences.

Starting a new MS treatment can be complicated—there are many barriers that might prevent patients from beginning the medication or sticking with it long-term. This study exists to identify those barriers and what helps people succeed, so doctors and healthcare systems can make the treatment easier to access and use.